Literature DB >> 20695460

Differential cellular responses to protein adducts of naphthoquinone and monocrotaline pyrrole.

Lynn S Nakayama Wong1, Michael W Lamé, A Daniel Jones, Dennis W Wilson.   

Abstract

Protein-xenobiotic adducts are byproducts of xenobiotic metabolism. While there is a correlation between protein adduction and target organ toxicity, a cause and effect relationship is not often clear. Naphthoquinone (NQ) and monocrotaline pyrrole (MCTP) are two pneumotoxic electrophiles that form covalent adducts with a similar select group of proteins rich in reactive thiols. In this study, we treated human pulmonary artery endothelial cells (HPAEC) with NQ, MCTP, or preformed NQ or MCTP adducts to the protein galectin-1 (gal-1) and examined indicators of reactive oxygen species (ROS) oxidative injury, markers of apoptosis (caspase-3 and annexin V), and gene responses of cellular stress. ROS production was assayed fluorescently using CM-H(2)DCFDA. NQ adducts to gal-1 (NQ-gal) produced 183% more intracellular ROS than gal-1 alone (p < 0.0001). Caspase-3 activity and annexin V staining of phosphatidylserine were used to assess apoptotic activity in treated cells. HPAEC exposed to MCTP-gal had increases in both caspase-3 activation and membrane translocation of annexin V relative to gal-1 alone (p < 0.0001). Direct application of NQ produced significantly more ROS and induced significant caspase-3 activation, whereas MCTP did not. Human bronchial epithelial cells were also exposed to MCTP-gal and found to have significant increases in both caspase-3 activation and annexin V staining in comparison to that of gal-1 (p < 0.05). Western blot analysis showed that both NQ and MCTP significantly induced the Nrf2 mediated stress response pathway despite differences in ROS generation. ER stress was not induced by either adducts or parent compounds as seen by quantitative RT-PCR, but HOX-1 expression was significantly induced by NQ-gal and MCTP alone. Electrophile adduction to gal-1 produces different cytotoxic effects specific to each reactive intermediate.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20695460      PMCID: PMC7839812          DOI: 10.1021/tx1002436

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  54 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Activation of the Nrf2-ARE signaling pathway: a promising strategy in cancer prevention.

Authors:  Aldo Giudice; Maurizio Montella
Journal:  Bioessays       Date:  2006-02       Impact factor: 4.345

3.  Discordant regulatory changes in monocrotaline-induced megalocytosis of lung arterial endothelial and alveolar epithelial cells.

Authors:  Somshuvra Mukhopadhyay; Pravin B Sehgal
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-01-13       Impact factor: 5.464

4.  Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy.

Authors:  Victor L J L Thijssen; Ruben Postel; Ricardo J M G E Brandwijk; Ruud P M Dings; Irina Nesmelova; Sietske Satijn; Nicole Verhofstad; Yusaku Nakabeppu; Linda G Baum; Jeroen Bakkers; Kevin H Mayo; Françoise Poirier; Arjan W Griffioen
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-16       Impact factor: 11.205

5.  Isolation and identification of a pyrrolic glutathione conjugate metabolite of the pyrrolizidine alkaloid monocrotaline.

Authors:  M W Lamé; D Morin; A D Jones; H J Segall; D W Wilson
Journal:  Toxicol Lett       Date:  1990-05       Impact factor: 4.372

Review 6.  Selective protein covalent binding and target organ toxicity.

Authors:  S D Cohen; N R Pumford; E A Khairallah; K Boekelheide; L R Pohl; H R Amouzadeh; J A Hinson
Journal:  Toxicol Appl Pharmacol       Date:  1997-03       Impact factor: 4.219

Review 7.  Drug bioactivation, covalent binding to target proteins and toxicity relevance.

Authors:  Shufeng Zhou; Eli Chan; Wei Duan; Min Huang; Yu-Zong Chen
Journal:  Drug Metab Rev       Date:  2005       Impact factor: 4.518

Review 8.  Bioreductive activation of quinones: a mixed blessing.

Authors:  A S Koster
Journal:  Pharm Weekbl Sci       Date:  1991-06-21

9.  Prolonged cell-cycle arrest associated with altered cdc2 kinase in monocrotaline pyrrole-treated pulmonary artery endothelial cells.

Authors:  H C Thomas; M W Lamé; D Morin; D W Wilson; H J Segall
Journal:  Am J Respir Cell Mol Biol       Date:  1998-07       Impact factor: 6.914

Review 10.  The shock of aging: molecular chaperones and the heat shock response in longevity and aging--a mini-review.

Authors:  Stuart K Calderwood; Ayesha Murshid; Thomas Prince
Journal:  Gerontology       Date:  2009-06-18       Impact factor: 5.140

View more
  4 in total

1.  Structural determinant of chemical reactivity and potential health effects of quinones from natural products.

Authors:  Tingting Tu; Daryl Giblin; Michael L Gross
Journal:  Chem Res Toxicol       Date:  2011-08-02       Impact factor: 3.739

2.  Polysulfide Na2S4 regulates the activation of PTEN/Akt/CREB signaling and cytotoxicity mediated by 1,4-naphthoquinone through formation of sulfur adducts.

Authors:  Yumi Abiko; Yasuhiro Shinkai; Takamitsu Unoki; Reiko Hirose; Takashi Uehara; Yoshito Kumagai
Journal:  Sci Rep       Date:  2017-07-06       Impact factor: 4.379

3.  Nrf2 Activator PB125® as a Potential Therapeutic Agent against COVID-19.

Authors:  Joe M McCord; Brooks M Hybertson; Adela Cota-Gomez; Kara P Geraci; Bifeng Gao
Journal:  Antioxidants (Basel)       Date:  2020-06-12

Review 4.  Pyrrole-protein adducts - A biomarker of pyrrolizidine alkaloid-induced hepatotoxicity.

Authors:  Jiang Ma; Qingsu Xia; Peter P Fu; Ge Lin
Journal:  J Food Drug Anal       Date:  2018-06-14       Impact factor: 6.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.